Reports

Sale

Global Central Nervous System (CNS) Stimulant Drugs Market: By Application: Attention-Deficit Hyperactivity Disorder, Narcolepsy, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032

Global Central Nervous System (CNS) Stimulant Drugs Market Outlook

The global central nervous system (CNS) stimulant drugs market size will expand at a CAGR of 6% in the forecast period of 2024-2032.

Global Central Nervous System (CNS) Stimulant Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The growing incidence of CNS disorders such as sleep apnea, narcolepsy, and hyperactivity of attention deficit, worldwide is increasing the sales and consumption of stimulant drugs for the central nervous system. Attention-deficit hyperactivity disorder, defined by inattention, hyperactivity, and impulsiveness, interferes with a person's growth and function. Hyperactivity disorder with attention deficit is prevalent among kids and adolescents. Similarly, during the day, chronic and excessive drowsiness attacks characterize narcolepsy, a neurological sleep disorder. The symptom is prevalent in early childhood kids and older adults of 50 years of age and the elderly. As a result, the growing incidences of CNS disorder during the forecast period will drive market growth.

Market Segmentation

Central nervous system (CNS) stimulants are brain-stimulating medications that accelerate both mental and physical processes. The high energy increases awareness and attention and boosts blood pressure, heart rate, and respiratory rate of the consumer.

Global Central Nervous System (CNS) Stimulant Drugs Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The central nervous system (CNS) stimulant drugs industry can be divided based on segments like application. The industry can be broadly categorised on the basis of application into:

Attention-Deficit Hyperactivity Disorder
Narcolepsy
Others

The EMR report looks into the regional markets of central nervous system (CNS) stimulant drugs like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.

Global Central Nervous System (CNS) Stimulant Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

For the treatment of central nervous system (CNS) disorders such as sleep apnea and attention-deficit hyperactivity disorder, medicinal marijuana has pharmacological benefits. Researchers discovered synthetic cannabinoids such as nabilone and dronabinol to be useful in treating individuals with sleep apnea owing to modulatory impacts on serotonin-mediated apneas. Cannabis can boost the amount of dopamine in an individual's brain suffering from hyperactivity disorder with attention deficit. The demand for cannabis legalization for therapeutic applications is, therefore, growing globally. This factor will increase the growth of the global market for the central nervous system (CNS) stimulant drugs.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global central nervous system (CNS) stimulant drugs market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

GlaxoSmithKline Plc
Novartis AG (NYSE: NVS)
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

Key Highlights of the Report

REPORT FEATURES	DETAILS
Base Year	2023
Historical Period	2017-2023
Forecast Period	2024-2032
Scope of the Report	Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment: Application Region
Breakup by Application	Attention-Deficit Hyperactivity Disorder Narcolepsy, Others
Breakup by Region	North America United States of America Canada Europe United Kingdom Germany France Italy Others Asia Pacific China Japan India ASEAN Australia Others Latin America Brazil Argentina Mexico Others Middle East and Africa Saudi Arabia United Arab Emirates Nigeria South Africa Others
Market Dynamics	SWOT Analysis Porter's Five Forces Analysis Key Indicators for Demand Key Indicators for Price
Competitive Landscape	Market Structure Company Profiles Company Overview Product Portfolio Demographic Reach and Achievements Certifications
Companies Covered	GlaxoSmithKline Plc Novartis AG Pfizer Inc. Teva Pharmaceutical Industries Ltd. Others
Report Price and Purchase Option	Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format	Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1   Preface
2   Report Coverage – Key Segmentation and Scope
3   Report Description
   3.1   Market Definition and Outlook
   3.2   Properties and Applications
   3.3   Market Analysis
   3.4   Key Players
4   Key Assumptions
5   Executive Summary
   5.1   Overview
   5.2   Key Drivers
   5.3   Key Developments
   5.4   Competitive Structure
   5.5   Key Industrial Trends
6   Snapshot
   6.1   Global
   6.2   Regional
7   Opportunities and Challenges in the Market
8   Global Central Nervous System (CNS) Stimulant Drugs Market Analysis
   8.1   Key Industry Highlights
   8.2   Global Central Nervous System (CNS) Stimulant Drugs Historical Market (2018-2023)
   8.3   Global Central Nervous System (CNS) Stimulant Drugs Market Forecast (2021-2027)
   8.4   Global Central Nervous System (CNS) Stimulant Drugs Market by Application
       8.4.1   Attention-Deficit Hyperactivity Disorder
8.4.1.1 Historical Trend (2018-2023)
           8.4.1.2 Forecast Trend (2021-2027)
       8.4.2   Narcolepsy
8.4.2.1 Historical Trend (2018-2023)
           8.4.2.2 Forecast Trend (2021-2027)
       8.4.3   Others
   8.5 Global Central Nervous System (CNS) Stimulant Drugs Market by Region
       8.5.1    North America
           8.5.1.1    Historical Trend (2018-2023)
           8.5.1.2    Forecast Trend (2024-2032)
       8.5.2    Europe
           8.5.2.1    Historical Trend (2018-2023)
           8.5.2.2    Forecast Trend (2024-2032)
       8.5.3    Asia Pacific
           8.5.3.1    Historical Trend (2018-2023)
           8.5.3.2    Forecast Trend (2024-2032)
       8.5.4    Latin America
             8.5.4.1    Historical Trend (2018-2023)
             8.5.4.2    Forecast Trend (2024-2032)
       8.5.5    Middle East and Africa
           8.5.5.1    Historical Trend (2018-2023)
           8.5.5.2    Forecast Trend (2024-2032)
9    North America Central Nervous System (CNS) Stimulant Drugs Market Analysis
   9.1    United States of America
       9.1.1    Historical Trend (2018-2023)
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023)
        9.2.2    Forecast Trend (2024-2032)
10    Europe Central Nervous System (CNS) Stimulant Drugs Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5   Others
11    Asia Pacific Central Nervous System (CNS) Stimulant Drugs Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023)
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Central Nervous System (CNS) Stimulant Drugs Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023)
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023)
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    GlaxoSmithKline Plc
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Novartis AG
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Pfizer Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Teva Pharmaceutical Industries Ltd.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Others
16    Key Trends and Developments in the Market

List of Key Figures and Tables

1.   Global Central Nervous System (CNS) Stimulant Drugs Market: Key Industry Highlights, 2018 and 2032
2.   Global Central Nervous System (CNS) Stimulant Drugs Historical Market: Breakup by Application (USD Million), 2018-2023
3.   Global Central Nervous System (CNS) Stimulant Drugs Market Forecast: Breakup by Application (USD Million), 2021-2027
4.   Global Central Nervous System (CNS) Stimulant Drugs Historical Market: Breakup by Region (USD Million), 2018-2023
5.   Global Central Nervous System (CNS) Stimulant Drugs Market Forecast: Breakup by Region (USD Million), 2021-2027
6.   North America Central Nervous System (CNS) Stimulant Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
7.   North America Central Nervous System (CNS) Stimulant Drugs Market Forecast: Breakup by Country (USD Million), 2021-2027
8.   Europe Central Nervous System (CNS) Stimulant Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
9.   Europe Central Nervous System (CNS) Stimulant Drugs Market Forecast: Breakup by Country (USD Million), 2021-2027
10.   Asia Pacific Central Nervous System (CNS) Stimulant Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
11.   Asia Pacific Central Nervous System (CNS) Stimulant Drugs Market Forecast: Breakup by Country (USD Million), 2021-2027
12.   Latin America Central Nervous System (CNS) Stimulant Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
13.   Latin America Central Nervous System (CNS) Stimulant Drugs Market Forecast: Breakup by Country (USD Million), 2021-2027
14.   Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
15.   Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Market Forecast: Breakup by Country (USD Million), 2021-2027
16.   Global Central Nervous System (CNS) Stimulant Drugs Market Structure

Key Questions Answered in the Report

What is the growth rate of the global central nervous system (CNS) stimulant drugs market?

The global central nervous system (CNS) stimulant drugs market is projected to grow at a CAGR of 6% between 2024 and 2032.

What are the major industry drivers?

The major drivers of the industry, such as the increasing prevalence of CNS disorder, growing legalisation of cannabis for medical purposes, and rapid technological advancements, are expected to aid the market growth.

What are the key industry trends of the global central nervous system (CNS) stimulant drugs market?

The key market trends guiding the growth of the industry include the growing research and development activities by the manufacturers are increasing clinical trials.

What are the major regional markets of central nervous system (CNS) stimulant drugs, according to the EMR report?

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

What are the leading applications of central nervous system (CNS) stimulant drugs in the industry?

Attention-deficit hyperactivity disorder and narcolepsy, among others, are the leading applications of central nervous system (CNS) stimulant drugs in the industry.

Who are the key industry players, according to the report?

The major players in the industry are GlaxoSmithKline Plc, Novartis AG (NYSE: NVS), Pfizer Inc., and Teva Pharmaceutical Industries Ltd., among others.

Analyst Review

The global central nervous system (CNS) stimulant drugs market is being driven by the growing cases of central nervous system disorders and advancement in technology. Aided by the growing investment in R&D activities, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on applications, the central nervous system (CNS) stimulant drugs industry can be segmented into attention-deficit hyperactivity disorder and narcolepsy, among others. The major regional markets for central nervous system (CNS) stimulant drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include GlaxoSmithKline Plc, Novartis AG (NYSE: NVS), Pfizer Inc., and Teva Pharmaceutical Industries Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Request Sample

Purchase Full Report

Mini Report

$ ~~2969~~ $2699

Selected Sections, One User
Printing Not Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Single User License

$ ~~5499~~ $4999

All Sections, One User
One Print Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Five User License

$ ~~6599~~ $5999

All Sections, Five Users
Five Prints Allowed
Email Delivery in PDF
Free Limited Customisation
Post Sales Analyst Support
~~50% Discount on Next Update~~

Buy Now

Corporate License

$ ~~7699~~ $6999

All Sections, Unlimited Users
Unlimited Prints Allowed
Email Delivery in PDF + Excel
Free Limited Customisation
Post Sales Analyst Support
50% Discount on Next Update

Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER